Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Njainday, Jobe"'
Publikováno v:
Cancers; Volume 14; Issue 24; Pages: 6077
Treatment of melanoma with a BRAF inhibitor (BRAFi) frequently initiates development of BRAFi resistance, leading to increased tumor progression and metastasis. Previously, we showed that combined inhibition of elevated WNT5A and IL-6 signaling reduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::6cb7d7db76d68b47519364be6e90cc68
Autor:
Vikas, Yadav, Njainday, Jobe, Shakti Ranjan, Satapathy, Purusottam, Mohapatra, Tommy, Andersson
Publikováno v:
Cancers. 14(24)
Treatment of melanoma with a BRAF inhibitor (BRAFi) frequently initiates development of BRAFi resistance, leading to increased tumor progression and metastasis. Previously, we showed that combined inhibition of elevated WNT5A and IL-6 signaling reduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b30cc29079e396c279128af0a1372446
https://pubmed.ncbi.nlm.nih.gov/36551563
https://pubmed.ncbi.nlm.nih.gov/36551563
Publikováno v:
Handbook of experimental pharmacology. 269
WNT signalling is known to be a crucial regulator of embryonic development and tissue homeostasis. Aberrant expression of WNT signalling elements or their mutations has been implicated in carcinogenesis and/or the progression of several different can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::71ebb6ac4c752e224a2440bb64f92a5c
https://pubmed.ncbi.nlm.nih.gov/34455485
https://pubmed.ncbi.nlm.nih.gov/34455485
Autor:
Yadav, Vikas1 (AUTHOR) vikas.yadav@med.lu.se, Jobe, Njainday1 (AUTHOR), Satapathy, Shakti Ranjan1 (AUTHOR), Mohapatra, Purusottam1,2 (AUTHOR), Andersson, Tommy1 (AUTHOR) vikas.yadav@med.lu.se
Publikováno v:
Cancers. 12/15/2022, Vol. 14 Issue 24, p6077. 22p.